Greenslopes Private Hospital is a private health care provider located in Greenslopes, Brisbane, Australia. It was named Australia's Best Private Hospital, 1999 and received the Australian Private Hospitals Association's, Hospital Quality of Excellence Award, 2004.

During the past decade, Greenslopes Private Hospital conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 12 clinical trials were completed, i.e. on average, 63.2% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Greenslopes Private Hospital" #1 sponsor was "Queensland Centre for Gynaecological Cancer" with 6 trials, followed by "Gilead Sciences" with 3 trials sponsored, "Prima BioMed Ltd" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Greenslopes Private Hospital" #1 collaborator was "The University of Queensland" with 4 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Cancer Australia" with 2 trials as a collaborator, "National Health and Medical Research Council, Australia" with 2 trials as a collaborator and "Queensland University of Technology" with 2 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 48 trials.

According to Clinical.Site data, the most researched conditions in "Greenslopes Private Hospital" are "Epithelial Ovarian Cancer" (4 trials), "Endometrial Cancer" (3 trials), "Melanoma" (3 trials), "Cervical Cancer" (2 trials) and "Chronic Hepatitis C" (2 trials). Many other conditions were trialed in "Greenslopes Private Hospital" in a lesser frequency.

Most popular intervention types in "Greenslopes Private Hospital" are "Drug" (19 trials), "Biological" (7 trials), "Device" (7 trials), "Procedure" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ipilimumab" (3 trials), "Avelumab" (2 trials), "Cvac" (2 trials), "Gemcitabine" (2 trials) and "Nivolumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Greenslopes Private Hospital" are 28 trials for "All" genders and 10 trials for "Female" genders.

Currently, there are NaN active trials in "Greenslopes Private Hospital". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Greenslopes Private Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Greenslopes Private Hospital, 4 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".